Pharmaceutical Pricing and Purchasing

Drug pricing must be in line with other provincial and territorial jurisdictions and must respect the balance between best price and patient needs. Savings accrued through improved pricing and purchasing policies should be reinvested into the BC PharmaCare program in order to provide better reimbursement coverage for new, improved medications.

Patient access to publicly funded medications should not be restricted by policies that limit pharmaceutical purchasing to sole product suppliers (sole tendering) across an entire class of chemically different drugs. Instead, purchasing policies for drugs that have been shown to be chemically identical (such a generics) should be incorporated as a way to reduce costs, while not limiting access and increasing risk to patients.

Pharmaceutical policy should not be based solely on cost "containment" as such policies restrict access to needed medications, thereby impeding appropriate and effective care, and increasing financial, human and social costs.